These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 32515392)

  • 1. Novel coronavirus disease pandemic and ophthalmologist's perspectives.
    Adhi MI
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S95-S97. PubMed ID: 32515392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-COV-2 in Ophthalmology: Current Evidence and Standards for Clinical Practice.
    Torres-Costa S; Lima-Fontes M; Falcão-Reis F; Falcão M
    Acta Med Port; 2020 Sep; 33(9):593-600. PubMed ID: 32662416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The COVID-19 Pandemic from an Ophthalmologist's Perspective.
    Bacherini D; Biagini I; Lenzetti C; Virgili G; Rizzo S; Giansanti F
    Trends Mol Med; 2020 Jun; 26(6):529-531. PubMed ID: 32470381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facing COVID-19 in Ophthalmology Department.
    Romano MR; Montericcio A; Montalbano C; Raimondi R; Allegrini D; Ricciardelli G; Angi M; Pagano L; Romano V
    Curr Eye Res; 2020 Jun; 45(6):653-658. PubMed ID: 32253942
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparedness among Ophthalmologists: During and Beyond the COVID-19 Pandemic.
    Olivia Li JP; Shantha J; Wong TY; Wong EY; Mehta J; Lin H; Lin X; Strouthidis NG; Park KH; Fung AT; McLeod SD; Busin M; Parke DW; Holland GN; Chodosh J; Yeh S; Ting DSW
    Ophthalmology; 2020 May; 127(5):569-572. PubMed ID: 32327128
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations on personal protective measures in ophthalmology (French Ophthalmology Society and National Council of Professionals in Ophthalmology) during this COVID-19 pandemic].
    Société Française d’Ophtalmologie. Electronic address: kodjikian.laurent@wanadoo.fr
    J Fr Ophtalmol; 2020 Jun; 43(6):529-530. PubMed ID: 32402411
    [No Abstract]   [Full Text] [Related]  

  • 7. Nosocomial COVID-19 transmission in routine ophthalmic practice-Is there new evidence?
    Honavar SG
    Indian J Ophthalmol; 2020 Oct; 68(10):2059-2060. PubMed ID: 32971606
    [No Abstract]   [Full Text] [Related]  

  • 8. All eyes on Coronavirus-
    Khanna RC; Honavar SG
    Indian J Ophthalmol; 2020 Apr; 68(4):549-553. PubMed ID: 32174565
    [No Abstract]   [Full Text] [Related]  

  • 9. Self-protection of medical workers in ophthalmology clinic during COVID-19 epidemic.
    Hua L; Zhu H; Liu H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):5155-5161. PubMed ID: 32432780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 and ophthalmology: an underappreciated occupational hazard.
    Kuo IC; O'Brien TP
    Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1207-1208. PubMed ID: 32412403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Considerations for transanal total mesorectal excision (TaTME) use during the COVID-19 pandemic.
    Lacy AM; De Lacy FB; Balibrea JM
    Br J Surg; 2020 Jun; 107(7):e203. PubMed ID: 32383490
    [No Abstract]   [Full Text] [Related]  

  • 12. The COVID-19 information pandemic: how have we managed the surge?
    Kearsley R; Duffy CC
    Anaesthesia; 2020 Aug; 75(8):993-996. PubMed ID: 32406517
    [No Abstract]   [Full Text] [Related]  

  • 13. Is it too premature to recommend against laparoscopic emergency surgery in COVID-19 patients?
    Yeo C; Yeo D; Kaushal S; Ahmed S
    Br J Surg; 2020 Jun; 107(7):e202. PubMed ID: 32379345
    [No Abstract]   [Full Text] [Related]  

  • 14. The Italian dermatologic community facing COVID-19 pandemic: recommendation from the Italian society of dermatology and venereology.
    Micali G; Musumeci ML; Peris K;
    G Ital Dermatol Venereol; 2020 Apr; 155(2):123-125. PubMed ID: 32394672
    [No Abstract]   [Full Text] [Related]  

  • 15. [Management guidelines for vulnerable workers and persons and SARS-CoV-2 in Catalonian businesses].
    Grupo de trabajo Grupo de trabajo para la elaboración de criterios para la gestión de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluña.GTPSVTESSARS-CoV-2
    Arch Prev Riesgos Labor; 2020 Apr; 23(2):234-252. PubMed ID: 32320546
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in the interaction of ophthalmologists and ophthalmic industry during and after COVID-19 lockdown: A perspective.
    Sanjay S; Garg A; Shetty N; Shetty R; Pindipapanahalli N; Shetty KB
    Indian J Ophthalmol; 2020 Jul; 68(7):1487-1488. PubMed ID: 32587210
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy.
    Jereczek-Fossa BA; Palazzi MF; Soatti CP; Cazzaniga LF; Ivaldi GB; Pepa M; Amadori M; Antognoni P; Arcangeli S; Buffoli A; Beltramo G; Berlinghieri S; Bignardi M; Bracelli S; Bruschieri L; Castiglioni S; Catalano G; Di Muzio N; Fallai C; Fariselli L; Filippi AR; Gramaglia A; Italia C; Lombardi F; Magrini SM; Nava S; Orlandi E; Pasinetti N; Sbicego EL; Scandolaro L; Scorsetti M; Stiglich F; Tonoli S; Tortini R; Valdagni R; Vavassori V; Marvaso G;
    Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):e160-e161. PubMed ID: 32354669
    [No Abstract]   [Full Text] [Related]  

  • 18. Fighting the COVID-19 pandemic: An ophthalmologist's experience in an intensive care unit at the All India Institute of Medical Sciences.
    Neupane S
    Indian J Ophthalmol; 2020 Jul; 68(7):1482. PubMed ID: 32587207
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronavirus and ophthalmology: What do we know and way forward.
    Khanna RC
    Indian J Ophthalmol; 2020 May; 68(5):942-944. PubMed ID: 32317500
    [No Abstract]   [Full Text] [Related]  

  • 20. Covid-19, ocular manifestation and ophthalmic risks.
    Joob B; Wiwanitkit V
    J Fr Ophtalmol; 2020 Sep; 43(7):e231. PubMed ID: 32553398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.